Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In research settings semaglutide is studied for its activity at the GLP-1 receptor in cell-based metabolic and incretin-pathway models
The stroke protocol calls for 6,000 mcg per day for 10 days, a dose substantially higher than standard nootropic use
J.LingG.WakabayashiN.et al
Active Chemical Compound : Body Protection Compound-157 (BPC-157) Industry Kit Designation : BPC-157 10mg (10mg Total Net Weight per Vial) Purity Threshold : 99.2% Verified via HPLC / Mass Spectrometry Physical State Form : Lyophilized White Powder (Vacuum Sealed Cake) Stabilizing Agent Matrix : Low-moisture Mannitol Excipient Base Regulatory Standing : Strictly for In Vitro and Laboratory Evaluation Only Chemical Profile and Mechanism of Action The BPC-157 peptide formulation consists of a pentadecapan peptide
When a low dose of aspirin is administered orally (most commonly 81 mg), its context-sensitive drug disposition via the portal circulation combined with the difference in IC50 values for COX-1 vs COX-2 both contribute significantly to the high selectivity by which low dose oral aspirin inhibits platelet COX-1 vs other COX-2 found in other nucleated tissues such as the vascular endothelium (Pedersen & FitzGerald, 1984
